FDA Names Darzalex ‘Breakthrough Therapy’ for Previously Treated Multiple Myeloma Patients
The U.S. Food and Drug Administration has designated Darzalex…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Drug Combo for Multiple Myeloma Fails in Overall Patient Survival
A randomized Phase 3 clincal trial has concluded that…
Immunotherapy Helps Myeloma Patients Who Relapse After Stem Cell Transplant, Study Shows
Many patients with blood cancers, such as myeloma, go…
Elevated BMI Linked to Multiple Myeloma Development and Progression
A study has uncovered that elevated body mass index…
Myeloma Development Might Be Stalled by Blocking Pathway from a Benign Condition, Study Says
Researchers at the University of Birmingham have found that…
Risk of Myeloma Still Small Despite Newly Revealed Gene Mutations
In the largest study to date, researchers from…
